Celgene Corp (NASDAQ:CELG)

103.24
Data as of Oct 24
 +2.84 / +2.83%
Today’s Change
66.85
Today|||52-Week Range
103.31
+22.20%
Year-to-Date
The Fab 5 Update
Oct 25 / StockTwits
Celgene (CELG) Q3 Earnings to Be Overrun by Expenses? - Analyst Blog
Oct 21 / Zacks.com
3 Stocks Reiterated As A Buy: MU, CAT, CELG
Oct 24 / TheStreet.com
Leadership Is Back
Oct 21 / TheStreet.com
Cramer Gives Thumbs-Up to 3M, Microsoft, Celgene Conference Calls
Oct 24 / TheStreet.com
Watch For Today's Momo Momentum Stock: Celgene (CELG)
Oct 21 / TheStreet.com
Aiming a Shotgun at Biotech
Oct 24 / TheStreet.com
Trading Activity Update
Oct 20 / StockTwits
Jim Cramer: Celgene, Gilead Leading Biotech Charge Higher
Oct 24 / TheStreet.com
3 Stocks Reiterated As A Buy: PFE, MU, CELG
Oct 20 / TheStreet.com
Jim Cramer on the Markets: 10 Names That Ignited Thursday's Rally
Oct 24 / TheStreet.com
First Detailed Look at Celgene Crohn's Disease Pill Impresses
Oct 20 / TheStreet.com
10 Names That Ignited Today's Rally
Oct 24 / TheStreet.com
Phase II Data In Crohn's Disease For Celgene's Oral Antisense Therapy GED-0301 To Be ...
Oct 20 / Benzinga
Jim Cramer's Top Stock Picks: CELG FTK BA JAH AVT
Oct 24 / TheStreet.com
Benzinga Weekly Preview: Earnings Season Is In Full Swing
Oct 19 / Benzinga
Celgene Beats Q3 Earnings Estimates on High Revlimid Sales - Analyst Blog
Oct 23 / Zacks.com
Agios (AGIO) Rises on Expansion of Phase I Study on AG-221 - Analyst Blog
Oct 16 / Zacks.com
Revlimid: Celgene Corporation's Gift That Keeps on Giving
Oct 23 / MotleyFool.com
A Quick Look at Celgene Corporation's Drug Development Pipeline
Oct 16 / MotleyFool.com
Stocks Hitting 52-Week Highs
Oct 23 / Benzinga
Where Will Celgene Corporation Stock Be a Year From Now?
Oct 14 / MotleyFool.com
Earnings Scheduled For October 23, 2014
Oct 23 / Benzinga
Celgene's Otezla Encourages in Plaque Psoriasis at EADV - Analyst Blog
Oct 13 / Zacks.com
3 Biotech Stocks Near 52-Week Highs Worth Selling
Oct 22 / MotleyFool.com
Cheap Stocks Wall Street Loves: Celgene Corporation
Oct 13 / MotleyFool.com
Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breaku...
Oct 22 / Zacks.com
The Fab 5 Update
Oct 04 / StockTwits
Celgene Corporation's Earnings Preview: Pay Attention to New Kids
Oct 22 / MotleyFool.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.